MGP
RMD icon

Metis Global Partners’s ResMed RMD Stock Holding History

Metis Global Partners’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$685K Sell
3,515
-625
-15% -$130K 0.02% 515
2026
Q1 		$929K Sell
4,140
-515
-11% -$128K 0.02% 453
2025
Q4 		$1.12M Sell
4,655
-317
-6% -$81.1K 0.03% 434
2025
Q3 		$1.36M Sell
4,972
-1,825
-27% -$498K 0.03% 407
2025
Q2 		$1.75M Sell
6,797
-923
-12% -$220K 0.05% 341
2025
Q1 		$1.73M Buy
7,720
+1,144
+17% +$267K 0.05% 340
2024
Q4 		$1.5M Sell
6,576
-214
-3% -$51.5K 0.05% 354
2024
Q3 		$1.66M Buy
6,790
+317
+5% +$70.8K 0.05% 331
2024
Q2 		$1.24M Sell
6,473
-113
-2% -$22.9K 0.04% 368
2024
Q1 		$1.3M Sell
6,586
-4
-0.1% -$733 0.05% 363
2023
Q4 		$1.13M Sell
6,590
-1,695
-20% -$260K 0.05% 374
2023
Q3 		$1.23M Buy
8,285
+1,368
+20% +$247K 0.06% 336
2023
Q2 		$1.51M Buy
6,917
+296
+4% +$66K 0.08% 262
2023
Q1 		$1.45M Buy
6,621
+1,100
+20% +$239K 0.09% 234
2022
Q4 		$1.15M Buy
5,521
+2,479
+81% +$545K 0.1% 225
2022
Q3 		$664K Buy
3,042
+375
+14% +$85.4K 0.11% 214
2022
Q2 		$559K Buy
2,667
+361
+16% +$76.9K 0.09% 264
2022
Q1 		$560K Buy
2,306
+1,036
+82% +$251K 0.07% 271
2021
Q4 		$331K Buy
+1,270
New +$330K 0.09% 241

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Metis Global Partners's RMD Position: Q2 2026 in Review

Metis Global Partners reduced its ResMed (RMD) stake by 15% in Q2 2026, selling an estimated $130K and leaving 3,515 shares worth $685K. The position accounts for 0.02% of the portfolio, ranked #515.

Metis Global Partners first reported a position in RMD in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.75M in Q2 2025. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Metis Global Partners held 3,515 shares of ResMed worth $685K as of Q2 2026.
  • Metis Global Partners sold 625 ResMed shares in Q2 2026, an estimated $130K.
  • ResMed made up 0.02% of Metis Global Partners's portfolio in Q2 2026, its #515 holding.
  • Metis Global Partners first reported a position in ResMed in Q4 2021 and has held it in 19 quarters since.
  • Metis Global Partners's ResMed position peaked at $1.75M in Q2 2025.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Metis Global Partners's 13F filing for Q2 2026, filed 10 Aug 2026.